- Trials with a EudraCT protocol (160)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
160 result(s) found for: Segments.
Displaying page 1 of 8.
EudraCT Number: 2020-004455-32 | Sponsor Protocol Number: IMB101-006 | Start Date*: 2021-02-16 |
Sponsor Name:Imbria Pharmaceuticals, Inc. | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Patients with Angina due to Coronary Syndrome | ||
Medical condition: Stable coronary artery disease (CAD) /Chronic coronary syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) FI (Completed) DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003770-25 | Sponsor Protocol Number: 3959 | Start Date*: 2008-02-21 |
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
Full Title: ACIDE TRANEXAMIQUE VERSUS PLACEBO DANS LA REDUCTION DES SAIGNEMENTS PERIOPERATOIRES APRES HEPATECTOMIES MAJEURES : ETUDE PROSPECTIVE RANDOMISEE EN DOUBLE AVEUGLE. | ||
Medical condition: Patients devant bénéficier d'une résection hépatique majeure (≥ 3 segments hépatiques). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007163-16 | Sponsor Protocol Number: PHRC-I/2008/VB-03 | Start Date*: 2009-06-11 |
Sponsor Name:CHU de Nîmes | ||
Full Title: La TEP-TDM au 18F-FDG : permet-elle d’optimiser les résultats de la scintigraphie à la I123-MIBG dans la recherche d’éléments discriminants pour l’implantation d’un défibrillateur implantable, en p... | ||
Medical condition: Insuffisance cardiaque d'origine ischémique | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-006052-37 | Sponsor Protocol Number: IOM/BRA/035 | Start Date*: 2006-04-13 |
Sponsor Name:Bracco ALTANA Pharma GmbH | ||
Full Title: COMPARISON OF IOMEPROL 300 AND IOMEPROL 400 FOR THE EFFICIENCY OF AUTOSEGMENTATION IN 64-ROW MULTI-DETECTOR CTA OF THE CORONARY ARTERIES | ||
Medical condition: Indication for coronary multi-detector computed tomographic angiography | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003735-23 | Sponsor Protocol Number: FE999169 | Start Date*: 2008-11-24 |
Sponsor Name:Ferring Pharmaceuticals Ltd. | ||
Full Title: A prospective, randomised study comparing a 3-sachet Picolax® treatment with the standard 2-sachet Picolax® for bowel cleansing prior to colonoscopy. | ||
Medical condition: Bowel preparation prior to elective complete colonoscopy. As 'bowel preparation' is not a specific medical condition, there is no MedDRA term. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-003638-17 | Sponsor Protocol Number: HEMOPURE II and/or COR-002 | Start Date*: 2005-10-28 |
Sponsor Name:Biopure Corporation | ||
Full Title: This is a phase II, open-label study in the catheterization laboratory setting to challenge the concept that HBOC-201 ® administration might improve myocardial ‘oxygenation’ and myocardial function... | ||
Medical condition: Treatment of several ischemic conditions, such as acute coronary syndromes (ACS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005946-38 | Sponsor Protocol Number: IOM/BRA/038 | Start Date*: Information not available in EudraCT |
Sponsor Name:Bracco ALTANA Pharma GmbH | ||
Full Title: A DOUBLE-BLIND INTER-INDIVIDUAL COMPARISON OF IOMEPROL 300 AND IOMEPROL 400 IN MULTI-DETECTOR CT ANGIOGRAPHY (MDCTA) OF PERIPHERAL ARTERIES | ||
Medical condition: Medical condition: indication for computed tomographic angiography of the peripheral arteries, in particular for diagnosis of peripheral arterial disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000994-69 | Sponsor Protocol Number: SOV302 | Start Date*: 2004-11-11 | |||||||||||
Sponsor Name:Amersham Buchler GmbH & Co KG an affiliate of GE Healthcare Bio-Sciences | |||||||||||||
Full Title: A multicentre, phase 3, open label study to assess the efficacy and safety of 0.1 mmol/kg Omniscan™ (gadodiamide injection) for Magnetic Resonance Angiography (MRA) of the aorto-iliac arteries | |||||||||||||
Medical condition: Suspected or proven chronic PAOD predominantly located in the aorto-iliac region of Fontaine Stages IIb to IV (ie, Rutherford Stages I3-III), or presents with an ankle brachial pressure index of <0... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) SE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006617-11 | Sponsor Protocol Number: 122021 | Start Date*: 2022-06-07 | ||||||||||||||||
Sponsor Name:Region Nordjylland | ||||||||||||||||||
Full Title: A Randomised controlled trial to compare efficacy and tolerability of Plenvu® and Picoprep® as cleansing agents before colonoscopy | ||||||||||||||||||
Medical condition: The trial is about comparing the efficacy of Plenvu with Picoprep. Both are bowel cleansing agents prior to colonoscopy. The patients to be examined are all referred to exclude colorectal cancer di... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023001-36 | Sponsor Protocol Number: BAY86-4875/14607 | Start Date*: 2011-04-26 | |||||||||||
Sponsor Name:Bayer Health Care AG | |||||||||||||
Full Title: Multicenter, open-label study to evaluate the safety and efficacy (by blinded reading) of contrast-enhanced magnetic resonance angiography (MRA) after a single intravenous injection of 0.1 mmol/k... | |||||||||||||
Medical condition: Subjects with known or suspected vascular disease of the supra-aortic vessels | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) SE (Completed) FR (Completed) IT (Completed) PL (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004034-41 | Sponsor Protocol Number: 21267983 | Start Date*: 2005-11-25 |
Sponsor Name:Genzyme Europe B.V. | ||
Full Title: Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure Phase 2 Study Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Study | ||
Medical condition: Ischemic Heart Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-002368-42 | Sponsor Protocol Number: LUM-001 | Start Date*: 2017-10-12 | |||||||||||
Sponsor Name:Lument AB | |||||||||||||
Full Title: An open, randomized, controlled, single centre trial to evaluate CT image quality and diagnostic feasibility of Lumentin® 44, a new egg albumen based oral bowel filling agent, in comparison with di... | |||||||||||||
Medical condition: None. Lumentin 44 is a contrast agent and the contrast properties will be investigated in this trial. Patients referred to computerised tomography of the abdomen will be included in the trial. Nei... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004875-41 | Sponsor Protocol Number: Dropizol_healthy_2020 | Start Date*: 2021-01-02 | |||||||||||
Sponsor Name:Mech-Sense, Aalborg University Hospital | |||||||||||||
Full Title: Opium tincture against chronic diarrhea - Healthy: An investigator initiated, randomized placebo-controlled, double-blinded, cross-over, clinical trial | |||||||||||||
Medical condition: Chronic diarrhea - The effect of opium tincture on the gastrointestinal function | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011002-42 | Sponsor Protocol Number: DGD-44-052 | Start Date*: 2009-05-29 | ||||||||||||||||
Sponsor Name:GUERBET | ||||||||||||||||||
Full Title: Intra-individual efficacy evaluation of DOTAREM®-enhanced MRA compared to GADOVIST®–enhanced MRA in the diagnosis of clinically significant abdominal or limb arterial diseases | ||||||||||||||||||
Medical condition: Patient suffering from Peripheral Arterial Occlusive Disease (PAOD) stage II or III | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-005308-15 | Sponsor Protocol Number: n/a | Start Date*: 2007-03-15 |
Sponsor Name:University Heidelberg, Department of General Surgery | ||
Full Title: Pilot study of the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection. | ||
Medical condition: postoperative infectious complications ICD classification code : T 81.4 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003179-23 | Sponsor Protocol Number: GS-US-419-4015 | Start Date*: 2017-04-13 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn’s Disease (SBCD) | |||||||||||||
Medical condition: Small Bowel Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) CZ (Completed) ES (Completed) PL (Completed) HU (Completed) FR (Completed) AT (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001448-33 | Sponsor Protocol Number: SELECT-AMI | Start Date*: 2011-06-28 | |||||||||||
Sponsor Name:Cardiovascular Centre Aalst [...] | |||||||||||||
Full Title: A multi-centre, double-blind, randomised, placebo-controlled trial using CD133 enriched bone marrow cells following primary angioplasty for acute myocardial infarction with central core laboratory ... | |||||||||||||
Medical condition: Patients with acute ST-elevated myocardial infarction treated with primary percutaneous coronary intervention | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) BE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002902-23 | Sponsor Protocol Number: PHRC2007-03 | Start Date*: 2008-02-11 |
Sponsor Name:CHU Angers, directeur général, Yvonnick Morice | ||
Full Title: EPOMI (ERYTHROPOIETIN IN MYOCARDIAL INFARCTION) : ESSAI RANDOMISE MULTICENTRIQUE EVALUANT L’EFFET D’UNE INJECTION D’ERYTHROPOÏETINE A LA PHASE AIGUË DE L’INFARCTUS DU MYOCARDE SUR LA TAILLE DE LA ... | ||
Medical condition: Infarctus du myocarde, syndrome coronarien aigu avec susdécalage du segment ST | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001974-11 | Sponsor Protocol Number: HEPATOTEST | Start Date*: 2013-08-29 |
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
Full Title: PILOT TRIAL FOR THE EVALUATION OF HEPATOTEST IN PREOPERATIVE ASSESSMENT IN LIVER FUNCTION. | ||
Medical condition: Patients with liver metastases (mainly colorectal cancer) who will be undergoing major hepatic resection (3 or more liver segments) which have been treated with neoadjuvant chemotherapy. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001962-25 | Sponsor Protocol Number: BR1-142 | Start Date*: 2016-03-04 | |||||||||||
Sponsor Name:Bracco Imaging S.p.A. | |||||||||||||
Full Title: A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis ... | |||||||||||||
Medical condition: Suspected or known Coronary Artery Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
